(Q39527872)

12 September 2017

1 reference

title

Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease (English)

1 reference

12 September 2017

1 reference

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

Weinberg GA

1

1 reference

PubMed ID

3050001

12 September 2017

Granoff DM

series ordinal

2

1 reference

PubMed ID

3050001

12 September 2017

language of work or name

English

0 references

publication date

1 October 1988

1 reference

The Journal of Pediatrics

12 September 2017

1 reference

12 September 2017

113

1 reference

12 September 2017

621-631

1 reference

12 September 2017

4

1 reference

Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Haemophilus influenzae type b polysaccharide vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Prospects for prevention of Haemophilus influenzae type b disease by immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : II. IMMUNOLOGICAL SPECIFICITY OF SYNTHETIC SUGAR-PROTEIN ANTIGENS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Thymus-independent antigens: complexity of B-lymphocyte activation revealed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Persistence of antibody and response to booster dose of Haemophilus influenzae type b polysaccharide diphtheria toxoid conjugate vaccine in infants immunized at 9 to 15 months of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Lack of comparability between commonly used serological assays of immune response to Haemophilus influenzae vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Immunochemical variables affecting radioantigen-binding assays of antibody to Haemophilus influenzae type b capsular polysaccharide in childrens' sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Antibody responses to Haemophilus influenzae type b polysaccharide vaccine in relation to Km(1) and G2m(23) immunoglobulin allotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Persistence of antibody to Haemophilus influenzae type b at 4 years of age in children previously immunized with polysaccharide antigen alone or conjugated with diphtheria toxoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Immunogenicity of the Haemophilus influenzae type b capsular polysaccharide conjugate vaccine in children after systemic Haemophilus influenzae type b infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Response to oligosaccharide-protein conjugate vaccine against Hemophilus influenzae b in two patients with IgG2 deficiency unresponsive to capsular polysaccharide vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Antibody responses of black children to Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein conjugate vaccine in relation to the Km(1) allotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(1) immunoglobulin allotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Immunogenicity of Haemophilus influenzae type b polysaccharide--diphtheria toxoid conjugate vaccine in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Relation of age, race, and allotype to immunoglobulin subclass concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Characterization of human antibody to polyribophosphate, the capsular antigen of hemophilus influenzae, type B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Genes Associated with the G2m(23) Immunoglobulin Allotype Regulate the IgG Subclass Responses to Haemophilus influenzae Type b Polysaccharide Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Serum opsonic activity for Haemophilus influenzae type b in infants immunized with polysaccharide-protein conjugate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Safety and Immunogenicity of Haemophilus influenzae Type B Polysaccharide-Diphtheria Toxoid Conjugate Vaccine in Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D) in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

Vaccines against encapsulated bacteria: a global agenda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Variable quantitation of Haemophilus influenzae type b anticapsular antibody by radioantigen binding assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980369-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(88)80369-X

1 reference

12 September 2017

1 reference

PubMed ID

3050001